Hanmi forges strategic tie-up with GSK

Published: 2012-03-30 06:58:00

Updated: 2012-03-30 06:58:00

Hanmi Pharmaceutical Co. announced yesterday it signed an agreement with GlaxoSmithKline (GSK), a U.K.-based pharmaceutical and health care company, to co-develop and commercialize combination products at the British company’s headquarters in Singapore.

The Korean and British drug manufacture...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK